150 related articles for article (PubMed ID: 10551800)
1. Changes in levels of normal ML-1 gene transcripts associated with the conversion of human nontumorigenic to tumorigenic phenotypes.
Sun XL; Li D; Fang J; Noyes I; Casto B; Theil K; Shuler C; Milo GE
Gene Expr; 1999; 8(2):129-39. PubMed ID: 10551800
[TBL] [Abstract][Full Text] [Related]
2. Cloning and sequencing of CATR1.3, a human gene associated with tumorigenic conversion.
Li D; Noyes I; Shuler C; Milo GE
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6409-13. PubMed ID: 7604004
[TBL] [Abstract][Full Text] [Related]
3. Malignant conversion of human cells by antisense cDNA to a putative tumor suppressor gene.
Li D; Yan H; Chen J; Casto BC; Theil KS; Milo GE
Carcinogenesis; 1996 Aug; 17(8):1751-5. PubMed ID: 8761437
[TBL] [Abstract][Full Text] [Related]
4. Metastatic conversion of chemically transformed human cells.
Sun XL; Li D; Fang J; Casto B; Noyes I; Milo GE
Gene Expr; 1999; 8(5-6):327-39. PubMed ID: 10947081
[TBL] [Abstract][Full Text] [Related]
5. Ineffectiveness of the presence of H-ras/p53 combination of mutations in squamous cell carcinoma cells to induce a conversion of a nontumorigenic to a tumorigenic phenotype.
Lee H; Li D; Prior T; Casto BC; Weghorst CM; Shuler CF; Milo GE
Cell Biol Toxicol; 1997 Oct; 13(6):419-34. PubMed ID: 9352120
[TBL] [Abstract][Full Text] [Related]
6. Identification of a human chromosome 11 gene which is differentially regulated in tumorigenic and nontumorigenic somatic cell hybrids of HeLa cells.
Lichy JH; Modi WS; Seuanez HN; Howley PM
Cell Growth Differ; 1992 Aug; 3(8):541-8. PubMed ID: 1390339
[TBL] [Abstract][Full Text] [Related]
7. Nontumorigenic squamous cell carcinoma line converted to tumorigenicity with methyl methanesulfonate without activation of HRAS or MYC.
Milo GE; Shuler C; Kurian P; French BT; Mannix DG; Noyes I; Hollering J; Sital N; Schuller D; Trewyn RW
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1268-72. PubMed ID: 2406716
[TBL] [Abstract][Full Text] [Related]
8. Malignant conversion of chemically transformed normal human cells.
Milo GE; Li D; Casto BC; Theil K; Shuler C; Noyes I; Chen J
Proc Natl Acad Sci U S A; 1996 May; 93(11):5229-34. PubMed ID: 8643558
[TBL] [Abstract][Full Text] [Related]
9. Chromosome losses in tumorigenic revertants of EJ/ras-expressing somatic cell hybrids.
Pratt CI; Wu SQ; Bhattacharya M; Kao C; Gilchrist KW; Reznikoff CA
Cancer Genet Cytogenet; 1992 Apr; 59(2):180-90. PubMed ID: 1316224
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus growth-transformed cells are converted to malignancy following transfection of a 1.3-kb CATR1 antisense construct independent of a change in the level of c-myc expression followed by a 8;14 chromosomal translocation.
Li D; Sun XL; Casto B; Fang J; Theil K; Glaser R; Milo G
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):4894-9. PubMed ID: 9560199
[TBL] [Abstract][Full Text] [Related]
11. Conversion of premalignant human cells to tumorigenic cells by methylmethane sulfonate and methylnitronitrosoguanidine.
Milo GE; Shuler CF; Stoner G; Chen JC
Cell Biol Toxicol; 1992; 8(4):193-205. PubMed ID: 1337307
[TBL] [Abstract][Full Text] [Related]
12. Functional evidence for a second tumor suppressor gene on human chromosome 17.
Chen P; Ellmore N; Weissman BE
Mol Cell Biol; 1994 Jan; 14(1):534-42. PubMed ID: 8264622
[TBL] [Abstract][Full Text] [Related]
13. Antisense inhibition of cyclin D1 in human head and neck squamous cell carcinoma.
Nakashima T; Clayman GL
Arch Otolaryngol Head Neck Surg; 2000 Aug; 126(8):957-61. PubMed ID: 10922227
[TBL] [Abstract][Full Text] [Related]
14. Noncorrelative c-myc and ras oncogene expression in squamous cell carcinoma cells with tumorigenic potential.
Shuler C; Kurian P; French BT; Noyes I; Sital N; Hollering J; Trewyn RW; Schuller D; Milo GE
Teratog Carcinog Mutagen; 1990; 10(1):53-65. PubMed ID: 1693449
[TBL] [Abstract][Full Text] [Related]
15. Stepwise genetic changes associated with progression of nontumorigenic HPV-18 immortalized human prostate cancer-derived cell line to a malignant phenotype.
Hukku B; Mally M; Cher ML; Peehl DM; Kung H; Rhim JS
Cancer Genet Cytogenet; 2000 Jul; 120(2):117-26. PubMed ID: 10942801
[TBL] [Abstract][Full Text] [Related]
16. Tumorigenic suppression of a human cutaneous squamous cell carcinoma cell line in the nude mouse skin graft assay.
Conway K; Morgan D; Phillips KK; Yuspa SH; Weissman BE
Cancer Res; 1992 Dec; 52(23):6487-95. PubMed ID: 1358434
[TBL] [Abstract][Full Text] [Related]
17. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
[TBL] [Abstract][Full Text] [Related]
18. Comparative stages of expression of human squamous carcinoma cells and carcinogen transformed keratinocytes.
Milo GE; Yohn J; Schuller D; Noyes I; Lehman T
J Invest Dermatol; 1989 Jun; 92(6):848-53. PubMed ID: 2470830
[TBL] [Abstract][Full Text] [Related]
19. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
20. Coamplification in tumors of KRAS2, type 2 inositol 1,4,5 triphosphate receptor gene, and a novel human gene, KRAG.
Heighway J; Betticher DC; Hoban PR; Altermatt HJ; Cowen R
Genomics; 1996 Jul; 35(1):207-14. PubMed ID: 8661122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
